122. Superficial siderosis Clinical trials / Disease details
Clinical trials : 4 / Drugs : 9 - (DrugBank : 3) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000021218 | 2024/09/30 | 26/02/2016 | An efficacy of iron chelator to superficial siderosis | An efficacy of iron chelator to superficial siderosis - EICHSS | superficial siderosis of CNS | deferiprone | Department of Neurology, Tokyo Medical and Dental University | NULL | Recruiting | 20years-old | Not applicable | Male and Female | 5 | Not applicable | Japan |
| 2 | NCT04890808 (ClinicalTrials.gov) | September 2021 | 12/5/2021 | Therapeutic Antioxidant Supplementation | Therapeutic Antioxidant Supplementation for Enhancement of Neural Protection From Free-iron Toxicity in Superficial Siderosis | Superficial Siderosis | Dietary Supplement: Inosine;Dietary Supplement: IP6 | Superficial Siderosis Research Alliance Inc. | NULL | Not yet recruiting | 16 Years | 77 Years | All | 50 | N/A | NULL |
| 3 | NCT04200664 (ClinicalTrials.gov) | February 7, 2020 | 10/12/2019 | Audiovestibular Function in Infratentorial Superficial Siderosis | Clinical and Imaging Biomarkers of Audiovestibular Function in Infratentorial Superficial Siderosis | Siderosis;Neurological Disorder;Rare Diseases;Age Related Hearing Loss;Presbycusis | Diagnostic Test: Hearing assessment;Diagnostic Test: Vestibular/balance assessment;Other: Quality of life assessment;Diagnostic Test: Olfactory (smell) function testing;Genetic: DNA bio-banking | University College, London | NIHR UCLH BRC;The Bernice Bibby Research Trust | Completed | 18 Years | N/A | All | 90 | United Kingdom | |
| 4 | JPRN-jRCTs031180438 | 01/04/2019 | 27/03/2019 | Evaluation of iron chelator administration, and cochlear implantation for superficial siderosis | Evaluation of iron chelator administration, and cochlear implantation for superficial siderosis - ECHACISS | Superficial siderosis siderosis, cerebellar ataxia, hearing loss, superficial siderosis | 1. Administration of Deferiprone orally 30mg/kg after every meal for 36 months. 2. Artificial cochlear implantation for severe hearing disturbance | Sanjo Nobuo | NULL | Recruiting | >= 20age old | Not applicable | Both | 50 | N/A | Japan |